Skip to main content
All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

Lobbying for GILEAD SCIENCES, INC. · A Life-Science Company advancing therapies against life-threatening diseases

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $80,000.00 income · posted Oct 20, 2025

Official filing document

 Lobbying activity 3
Budget/Appropriations

federal budget issues

Health Issues

IRA, pharmaceuticals access and affordability, drug pricing in federal programs, HCV screening, drug pricing and access, HIV, oncology, PAHPA reauthorization

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem